Quarterly report pursuant to Section 13 or 15(d)

Investments in Other Entities (Tables)

v3.8.0.1
Investments in Other Entities (Tables)
3 Months Ended
Mar. 31, 2018
Equity Method Investments
Investments in other entities – equity method consisted of the following:
  
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
 
 
 
 
 
Universal Care, Inc.
 
$
8,589,253
 
$
8,609,455
 
LaSalle Medical Associates – IPA Line of Business
 
 
9,099,975
 
 
9,452,767
 
Diagnostic Medical Group
 
 
2,176,453
 
 
1,847,411
 
Pacific Medical Imaging & Oncology Center, Inc.
 
 
1,374,668
 
 
1,400,693
 
Pacific Ambulatory Surgery Center, LLC
 
 
635,151
 
 
593,198
 
 
 
 
 
 
 
 
 
 
 
$
21,875,500
 
$
21,903,524
 
LaSalle Medical Associates IPA [Member]  
Equity Method Investments
LMA’s IPA line of business summarized balance sheets at March 31, 2018 and December 31, 2017 and summarized statements of income for the three months ended March 31, 2018 and 2017 are as follows (unaudited):
 
Balance Sheets
 
 
 
March 31, 2018
(unaudited)
 
December 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
22,064,701
 
$
21,065,105
 
Receivables, net
 
 
3,005,144
 
 
2,433,116
 
Other current assets
 
 
2,173,110
 
 
1,565,606
 
Loan receivable
 
 
1,250,000
 
 
1,250,000
 
Restricted cash
 
 
664,612
 
 
662,109
 
 
 
 
 
 
 
 
 
Total assets
 
$
29,157,567
 
$
26,975,936
 
 
Liabilities and Stockholders’ Equity
 
 
 
March 31, 2018
(unaudited)
 
December 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
23,946,133
 
$
20,353,337
 
Stockholders’ equity
 
 
5,211,434
 
 
6,622,599
 
 
 
 
 
 
 
 
 
Total liabilities and stockholders’ equity
 
$
29,157,567
 
$
26,975,936
 
 
Statements of Income
 
 
 
March 31, 2018
(unaudited)
 
March 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Revenues
 
$
52,983,791
 
$
49,753,004
 
Expenses
 
 
54,002,458
 
 
44,506,050
 
 
 
 
 
 
 
 
 
Net (loss) income
 
$
(1,018,667)
 
$
5,246,954
 
Universal Care Inc [Member]  
Equity Method Investments
UCI’s balance sheets at March 31, 2018 and December 31, 2017 and statements of income for the three months ended March 31, 2018 and 2017 are as follows:
 
Balance Sheets
 
 
 
March 31, 2018
(unaudited)
 
December 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Cash
 
$
22,595,206
 
$
21,872,894
 
Receivables, net
 
 
23,862,184
 
 
18,618,760
 
Other current assets
 
 
18,870,831
 
 
13,021,520
 
Other assets
 
 
2,259,507
 
 
3,754,470
 
Property and equipment, net
 
 
1,770,157
 
 
1,576,621
 
 
 
 
 
 
 
 
 
Total assets
 
$
69,357,885
 
$
58,844,265
 
 
Liabilities and Stockholders’ Deficit
 
 
 
March 31, 2018
(unaudited)
 
December 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Current liabilities
 
$
64,984,078
 
$
54,421,532
 
Other liabilities
 
 
10,044,340
 
 
10,051,952
 
Stockholders’ deficit
 
 
(5,670,533)
 
 
(5,629,219)
 
 
 
 
 
 
 
 
 
Total liabilities and stockholders’ deficit
 
$
69,357,885
 
$
58,844,265
 
 
Statements of Income Operations
 
 
 
March 31, 2018
(unaudited)
 
March 31, 2017
(unaudited)
 
 
 
 
 
 
 
 
 
Revenues
 
$
72,665,437
 
$
46,540,892
 
Expenses
 
 
72,154,950
 
 
44,757,246
 
 
 
 
 
 
 
 
 
Income before provision for income taxes
 
 
510,487
 
 
1,783,646
 
Provision for income taxes
 
 
551,800
 
 
713,500
 
 
 
 
 
 
 
 
 
Net (loss) income
 
$
(41,313)
 
$
1,070,146